AMN
AMN Healthcare Services, Inc.15.82
-0.17-1.06%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
607.71MP/E (TTM)
-Basic EPS (TTM)
-7.20Dividend Yield
0%Recent Filings
8-K
8-K
AMN refinances 2027 notes with new debt
AMN Healthcare's subsidiary issued $400 million in 6.5% senior notes due 2031 on October 6, 2025, while amending its credit agreement to extend the revolving facility's maturity to October 6, 2030, shrink it from $750 million to $450 million, and ease leverage covenants to 5.25x through March 2027. These moves will fund the redemption of $500 million in 2027 notes on October 22, 2025, using $100 million in new borrowings, note proceeds, and cash. This refinances shorter-term debt at a higher rate, but stretches maturities and loosens terms amid market pressures. Debt swap extends runway.
10-Q
Q2 FY2025 results
AMN Healthcare's Q2 revenue fell 11% year-over-year to $658.2 million, driven by a 14% drop in nurse and allied solutions amid lower traveler volumes and visa delays, while physician solutions eased 6% on softer locum tenens demand yet higher rates per day filled. Gross margins slipped to 29.8% from 31.0%, pressured by rising provider pay, but operating losses stemmed mainly from a $109.5 million goodwill impairment in physician solutions and $18.3 million long-lived asset write-down in revenue cycle—net loss widened to $116.2 million, or $(3.02) diluted EPS, versus $16.2 million profit last year. Cash from operations held steady at $171.2 million year-to-date, funding $141.4 million in debt paydown to leave $70.0 million drawn on the $750.0 million revolver; free cash flow reached $151.4 million after $19.8 million capex. On July 1, 2025, AMN sold its Smart Square software for $65.3 million cash plus a $10.0 million note due 2027. Yet competition in staffing intensifies pricing risks.
8-K
AMN Q2 revenue drops 11%
AMN Healthcare reported Q2 2025 revenue of $658 million, down 11% year-over-year, with adjusted EBITDA of $58.3 million and a GAAP net loss of $116 million driven by $128 million in non-cash impairment charges. The allied staffing unit outperformed projections, while travel nursing fell 25% amid policy uncertainty slowing client decisions. In July, AMN sold Smart Square for $75 million, cutting annualized revenue by $17 million but forging a tech partnership. Q3 guidance projects $610-$625 million revenue, down 9-11% year-over-year. Strong cash flow reduced debt by $80 million.
10-Q
Q1 FY2025 results
AMN Healthcare's Q1 revenue fell 16% year-over-year to $689.5M, driven by a 20% drop in nurse and allied solutions to $413.3M amid lower traveler volumes, though labor disruption services surged $39M. Gross profit slid 23% to $198.1M with margins contracting to 28.7% from 31.4%, reflecting higher clinician pay packages, while operating income shrank to $12.5M from $39.9M. Diluted EPS turned negative at $(0.03), consistent with 38,312k shares and no anti-dilution. Cash from operations climbed to $92.7M, yielding $82.7M free cash flow (derived) after $10.0M capex; revolver drawdown to $150M left $579.6M available, backed by $55.8M cash. Net loss exceeded operating profit due to $12.3M interest. Declining demand for contingent labor persists as a key risk.
IPO
Employees
Sector
Industry
AMS
American Shared Hospital Servic
2.13-0.01
AONC
American Oncology Network, Inc.
11.12+0.00
CCRN
Cross Country Healthcare, Inc.
8.17-0.08
HCA
HCA Healthcare, Inc.
469.79-7.19
HCSG
Healthcare Services Group, Inc.
19.09-0.27
MAN
ManpowerGroup
29.31-0.23
NUTX
Nutex Health Inc.
171.72-4.06
SRXH
SRX Health Solutions, Inc.
0.38+0.07
SYRA
Syra Health Corp.
0.07+0.01
UHS
Universal Health Services, Inc.
222.64-1.23